Incensole acetate

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Incensole acetate is a novel anti-inflammatory compound that inhibits NF-κB activation.

Incensole acetate is a novel anti-inflammatory compound that inhibits NF-κB activation.

Incensole acetate (100 μM; pre-treatment 4 hours) significantly ameliorates Aβ 25–35-induced cell death, a 48–52% decrease in cell viability at Aβ25–35 is restored to 85–89% upon pre-treatment with IA.Incensole acetate (5-100 μM) pretreatment reverses increase in the mRNA and protein level of Bax, caspase 8, cyto c and decrease in the mRNA and protein level of Bcl2 induced by Aβ 25–35 in hOBNSCs. Cell Viability Assay Cell Line:Human olfactory bulb neural stem cells Concentration:100 μM Incubation Time:Pre-treatment 4 hours Result:Increased hOBNSCs cell viability induced by Aβ 25-35.

——

——

Others

Other Targets

——

——

——

34701-53-6

348.5

C22H36O3

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (286.93 mM)

——

——

(-20℃)

With Ice Pack

≥ 2 years